<SEC-DOCUMENT>0001213900-25-039303-index.html : 20250502
<SEC-HEADER>0001213900-25-039303.hdr.sgml : 20250502
<ACCEPTANCE-DATETIME>20250502171147
ACCESSION NUMBER:		0001213900-25-039303
CONFORMED SUBMISSION TYPE:	F-3
PUBLIC DOCUMENT COUNT:		11
FILED AS OF DATE:		20250502
DATE AS OF CHANGE:		20250502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Enlivex Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001596812
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286956
		FILM NUMBER:		25909886

	BUSINESS ADDRESS:	
		STREET 1:		37 DEREH MENACHEM BEGIN ST.
		STREET 2:		15TH FLOOR
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6522042
		BUSINESS PHONE:		972 (0) 3 7326616

	MAIL ADDRESS:	
		STREET 1:		37 DEREH MENACHEM BEGIN ST.
		STREET 2:		15TH FLOOR
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6522042

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Bioblast Pharma Ltd.
		DATE OF NAME CHANGE:	20160919

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIO BLAST PHARMA LTD.
		DATE OF NAME CHANGE:	20140113
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-3
<SEQUENCE>1
<FILENAME>ea0240501-f3_enlivex.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
Document 1 - file: ea0240501-f3_enlivex.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>ea024050101ex5-1_enlivex.htm <DESCRIPTION>OPINION OF FISCHER (FBC & CO.) <TEXT> Document 2 - file: ea024050101ex5-1_enlivex.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.2 <SEQUENCE>3 <FILENAME>ea024050101ex5-2_enlivex.htm <DESCRIPTION>OPINION OF GREENBERG TRAURIG, P.A. <TEXT> Document 3 - file: ea024050101ex5-2_enlivex.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>4 <FILENAME>ea024050101ex23-1_enlivex.htm <DESCRIPTION>CONSENT OF YAREL + PARTNERS, INDEPENDENT REGISTERED CERTIFIED PUBLIC ACCOUNTING FIRM <TEXT> Document 4 - file: ea024050101ex23-1_enlivex.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>5 <FILENAME>ea024050101ex-fee_enlivex.htm <DESCRIPTION>FILING FEE TABLE <TEXT> Document 5 - file: ea024050101ex-fee_enlivex.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>image_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: image_002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>ex5-1_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: ex5-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>ex5-2_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 8 - file: ex5-2_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>ex23-1_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 9 - file: ex23-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>10 <FILENAME>ex23-1_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 10 - file: ex23-1_002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>11 <FILENAME>ex23-1_003.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 11 - file: ex23-1_003.jpg
</DOCUMENT> </SEC-DOCUMENT>